About Option Care Health, Inc.
https://www.optioncarehealth.comOption Care Health, Inc. offers home and alternate site infusion services in the United States.
CEO
John C. Rademacher
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-02-03 | Reverse | 1:4 |
ETFs Holding This Stock
Summary
Showing Top 3 of 211
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
B of A Securities
Buy
Deutsche Bank
Buy
UBS
Buy
Jefferies
Buy
Citizens
Market Outperform
JMP Securities
Market Outperform
Grade Summary
Showing Top 6 of 9
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:21M
Value:$745.73M
BLACKROCK, INC.
Shares:20.17M
Value:$716.24M
VANGUARD GROUP INC
Shares:17.69M
Value:$628.06M
Summary
Showing Top 3 of 424
About Option Care Health, Inc.
https://www.optioncarehealth.comOption Care Health, Inc. offers home and alternate site infusion services in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.44B ▲ | $188.4M ▲ | $51.82M ▲ | 3.61% ▲ | $0.32 ▲ | $155.63M ▲ |
| Q2-2025 | $1.42B ▲ | $186.33M ▲ | $50.52M ▲ | 3.57% ▲ | $0.31 ▲ | $100.26M ▲ |
| Q1-2025 | $1.33B ▼ | $183.86M ▲ | $46.74M ▼ | 3.51% ▼ | $0.28 ▼ | $93.16M ▼ |
| Q4-2024 | $1.35B ▲ | $181.34M ▲ | $60.13M ▲ | 4.47% ▲ | $0.36 ▲ | $109.4M ▲ |
| Q3-2024 | $1.28B | $171.66M | $53.86M | 4.21% | $0.32 | $101.13M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $309.82M ▲ | $3.48B ▲ | $2.12B ▲ | $1.36B ▼ |
| Q2-2025 | $198.82M ▲ | $3.38B ▲ | $2.02B ▲ | $1.36B ▲ |
| Q1-2025 | $171.37M ▼ | $3.31B ▼ | $1.96B ▼ | $1.35B ▼ |
| Q4-2024 | $412.56M ▼ | $3.42B ▼ | $2.02B ▲ | $1.4B ▼ |
| Q3-2024 | $483.03M | $3.43B | $2B | $1.43B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $51.82M ▲ | $139.44M ▲ | $-11.72M ▼ | $-16.71M ▲ | $111M ▲ | $157.9M ▲ |
| Q2-2025 | $50.52M ▲ | $90.33M ▲ | $-9.02M ▲ | $-53.87M ▲ | $27.45M ▲ | $81.24M ▲ |
| Q1-2025 | $46.74M ▼ | $-7.21M ▼ | $-126.69M ▼ | $-107.29M ▼ | $-241.19M ▼ | $-16.59M ▼ |
| Q4-2024 | $60.13M ▲ | $36.12M ▼ | $-11.2M ▼ | $-95.38M ▼ | $-70.46M ▼ | $25.78M ▼ |
| Q3-2024 | $53.86M | $160.4M | $-9.67M | $-44.58M | $106.15M | $150.73M |
Revenue by Products
| Product | Q2-2015 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Reportable Segment | $0 ▲ | $1.33Bn ▲ | $1.42Bn ▲ | $1.44Bn ▲ |
 PBM Services | $20.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
CEO
John C. Rademacher
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2020-02-03 | Reverse | 1:4 |
ETFs Holding This Stock
Summary
Showing Top 3 of 211
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
B of A Securities
Buy
Deutsche Bank
Buy
UBS
Buy
Jefferies
Buy
Citizens
Market Outperform
JMP Securities
Market Outperform
Grade Summary
Showing Top 6 of 9
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:21M
Value:$745.73M
BLACKROCK, INC.
Shares:20.17M
Value:$716.24M
VANGUARD GROUP INC
Shares:17.69M
Value:$628.06M
Summary
Showing Top 3 of 424